Over 200 Researchers and Faculty Attend GCP-GLP Training at KIMS
The Good Clinical Practice (GCP)–Good Laboratory Practice (GLP) Training Programme was successfully conducted on 19th June 2026 at Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar, under the aegis of the Institutional Ethics Committee (IEC), KIMS. It was attended by more than two hundred faculty members, IEC members and postgraduates of KIMS.
The programme was conceptualized and envisioned by Dean and Principal of KIMS Prof. (Dr.) R C Das and successfully conducted by Prof. (Dr.) Alpana Mishra, Member Secretary, IEC, KIMS, along with Dr. Vartika, the IEC team and the postgraduates of community medicine. The programme was held with an objective to enhance researchers’ understanding of ethical clinical research, good laboratory practices, and regulatory requirements.
GCP-GLP Training at KIMS
The inaugural session was graced by the Dean & Principal , KIMS, Prof(Dr.) R C Das ; Prof. (Dr.) Lalatendu Mohanty, Vice Principal, KIMS, and Prof. (Dr.) Subhranshu Patra, Associate Dean of Research, KIMS. Faculty members, postgraduate students, and IEC members actively participated in the programme.
The scientific sessions were led by eminent experts. Prof. Bikash Medhi, PGIMER, Chandigarh, delivered sessions on research question formulation, critical thinking, Good Clinical Practice principles, and ethical conduct of clinical trials. He emphasised the importance of identifying research gaps, framing meaningful objectives, maintaining quality assurance, and ensuring participant safety through adherence to GCP guidelines.
Dr. Jaya Singh Kshatri, Scientist D, ICMR, Bhubaneswar, conducted an interactive session on biostatistics and sample size estimation. He highlighted key statistical concepts, data management, the importance of robust statistical planning, and its importance in the ethical conduct of research.
Prof. Medhi discussed the ICMR Guidelines for Biomedical and Health Research, focusing on ethical principles such as autonomy, beneficence, non-malfeasance, and justice.
The concluding session covered Serious Adverse Event (SAE) reporting, compensation in clinical trials, and the New Drugs and Clinical Trials Rules, 2019, emphasizing regulatory compliance and participant protection.
The programme concluded with feedback from faculties and a vote of thanks by member secretary IEC. It was a highly enriching academic exercise. It will significantly strengthen participants’ knowledge of ethical research practices, clinical trial conduct, and regulatory requirements, reinforcing KIMS’s commitment to high-quality and ethically conducted biomedical research.